P And L Development Company Profile
✉ Email this page to a colleague
What is the competitive landscape for P AND L DEVELOPMENT, and what generic and branded alternatives to P AND L DEVELOPMENT drugs are available?
P AND L DEVELOPMENT has one approved drug.
Summary for P And L Development
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for P And L Development
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P And L Development | DOCOSANOL | docosanol | CREAM;TOPICAL | 212385-001 | Oct 7, 2022 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
